You are here



Congress Supporters - Thank You

Our 2021 World Congress wouldn't have been possible without the generous support of our Exhibitors and Sponsors. We encourage you to take a moment to learn more about our 2021 exhibitors.  If you didn't have a chance to visit the Exhibit Hall during the Congress, it's not too late to visit each of the exhibit booths.    


2021 Virtual World Congress Sponsors


Pfizer/Lilly - Learn more and visit their virtual Exhibit Booth

Joint Academy - Joint Academy is a virtual clinic that connects patients with licensed physical therapists to deliver an online treatment for chronic joint pain. The clinically proven treatment includes unlimited direct access to licensed physical therapists, an individualized exercise program, interactive education, and progress tracking. Visit their Exhibit Booth

Organogenesis -- Organogenesis offers a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Organogenesis’s versatile portfolio is designed to treat a variety of patients with repair and regenerative needs.  Visit their Exhibit Booth and schedule an appointment to learn more.

Sublimed -  Our device, actiTENS is both CE mark & FDA cleared. actiTENS is the only App-enabled tens clinically proven as more effective and better tolerated than weak opioid, offering a drug-free therapy to relieve pain safely.   Miniaturized & flexible, actiTENS helps patients managing their pain while remaining totally invisible, hidden under clothes. Key patient metrics are collected via the App to improve therapy’s success by keeping patients engaged and practitioners informed of the observance of the treatment.  Learn more and visit their Exhibit Booth.

TLC – Taiwan Liposome Company -  TLC (NASDAQ: TLC, TWO: 4152) is a clinical-stage, specialty pharmaceutical company dedicated to the research and development of novel nanomedicines in pain management that maximize the potential of its proprietary lipid-assembled drug delivery platforms (LipAD®), which are versatile in the choice of active pharmaceutical ingredients and scalable in manufacturing. Lead programs include TLC599 for osteoarthritis (OA) pain and TLC590 for postsurgical pain, which can potentially provide pain relief that lasts twice as long as current standards of care with a single administration, along with reduced toxicities.  Learn more and visit their Exhibit Booth.

Ultragenyx - Ultragenyx is a biopharmaceutical company committed to bringing to patients novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. Founded in 2010, the company has rapidly built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology, for which there are no approved therapies. Learn more and visit their Exhibit Booth.

Get Involved with a Community of Like-minded Professionals

OARSI gives you the opportunity to become part of a community of expert researchers and clinicians who are dedicated to improving the lives of millions of people affected by osteoarthritis. OARSI can help you make beneficial connections with individuals and organizations worldwide that are at the forefront of OA research, knowledge, and expertise while helping to raise your organization’s profile and awareness within the OA community

Our Promise

OARSI leads the advancement of understanding, early detection, treatment, and prevention of osteoarthritis through its Pillars of Excellence that include international collaboration, education, professional development, productive partnerships and the creation and dissemination of expert resources and knowledge.

View the Sponsorship Prospectus

For questions about becoming a 2020 Sponsor, Supporter, or Exhibitor, please contact our Industry Relations Manager:

Dana Groves


2021 Industry Partners


2021 Virtual World Congress Sponsors


2020 Industry Partners: Arthritis Knee Pain Centers, Flexion, EMD Serono/Merck, Mylan, Novartis, Pfizer, Samumed, Seikagaku, Teva/Regeneron

2019 Industry Partners:  Flexion, EMD Serono/Merck, Mylan, Pfizer, Samumed, Seikagaku

2018 Industry Partners:  Flexion, Merck, Mylan, Samumed, Seikagaku, Thuasne


Featured Resources

OARSI White Paper- OA as a Serious Disease

By Various

Patient Summary- Non Surgical Treatment of Knee Osteoarthritis

By Multiple Authors